Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AVAH 
Aveanna Healthcare Holdings Inc (AVAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/08/2026: AVAH (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $10.65
1 Year Target Price $10.65
| 1 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 4.21% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/08/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.85B USD | Price to earnings Ratio 23.97 | 1Y Target Price 10.65 |
Price to earnings Ratio 23.97 | 1Y Target Price 10.65 | ||
Volume (30-day avg) 8 | Beta 2.06 | 52 Weeks Range 3.67 - 10.32 | Updated Date 01/8/2026 |
52 Weeks Range 3.67 - 10.32 | Updated Date 01/8/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.37 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.29% | Operating Margin (TTM) 11% |
Management Effectiveness
Return on Assets (TTM) 9.31% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE 23.97 | Forward PE 15.08 | Enterprise Value 3052234967 | Price to Sales(TTM) 0.81 |
Enterprise Value 3052234967 | Price to Sales(TTM) 0.81 | ||
Enterprise Value to Revenue 1.33 | Enterprise Value to EBITDA 11.65 | Shares Outstanding 208911383 | Shares Floating 68894796 |
Shares Outstanding 208911383 | Shares Floating 68894796 | ||
Percent Insiders 5.44 | Percent Institutions 92.05 |
Upturn AI SWOT
Aveanna Healthcare Holdings Inc
Company Overview
History and Background
Aveanna Healthcare Holdings Inc. was founded in 2017 through the combination of multiple home healthcare providers, including Premier Home Healthcare and interim Healthcare. The company has grown significantly through acquisitions to become a leading provider of home-based care services. Its evolution has been driven by a strategy of consolidating fragmented markets and expanding its service offerings.
Core Business Areas
- Home Health: Provides a range of skilled nursing services, therapy (physical, occupational, speech), and medical social work to patients in their homes. This segment focuses on post-acute care, chronic disease management, and rehabilitation.
- Private Duty Services: Offers continuous, in-home nursing care for pediatric and adult patients with complex medical needs. This includes care for medically fragile children requiring specialized support and adults managing chronic conditions.
- Infusion Services: Delivers therapeutic infusions and related services in the home or at outpatient infusion centers. This includes antibiotics, nutritional support, and other complex therapies.
Leadership and Structure
Aveanna Healthcare Holdings Inc. is led by a senior management team responsible for strategic direction and operational oversight. The organizational structure is typically segmented by service line and geographic region to manage its extensive network of care centers and patients.
Top Products and Market Share
Key Offerings
- Skilled Nursing at Home: Provides professional nursing care, wound care, medication management, and patient education in a home setting. Competitors include LHC Group (LHCG), Amedisys (AMED), and other regional home health agencies. Market share data is not readily available at the product level, but the company is a significant player in the overall home health market.
- Pediatric Private Duty Nursing: Offers specialized, ongoing nursing care for children with complex medical conditions, including ventilator support, G-tube feeding, and seizure management. Competitors include hospitals' home care divisions and smaller, specialized pediatric home care providers. Market share is fragmented, with Aveanna holding a notable position.
- Home Infusion Therapy: Administers intravenous medications and therapies in a patient's home, reducing hospital stays and improving patient comfort. Competitors include large pharmacy benefit managers with infusion arms and specialized infusion pharmacies like Option Care Health (OPCH). Market share is highly competitive.
Market Dynamics
Industry Overview
The home healthcare industry is characterized by an aging population, increasing prevalence of chronic diseases, and a preference for home-based care over institutional settings. Regulatory changes, reimbursement rates from Medicare and Medicaid, and the demand for skilled nursing professionals are key drivers and challenges.
Positioning
Aveanna Healthcare Holdings Inc. is positioned as a comprehensive provider of home-based care, offering a broad spectrum of services from skilled nursing to complex pediatric care and infusion services. Its key competitive advantages include its scale, integrated service model, and a large network of caregivers.
Total Addressable Market (TAM)
The TAM for home healthcare in the US is substantial and growing, driven by demographic trends and the shift towards value-based care. While specific TAM figures vary, it is in the tens of billions of dollars annually. Aveanna Healthcare Holdings Inc. is a significant player within this market, though its market share is distributed across various sub-segments.
Upturn SWOT Analysis
Strengths
- Extensive geographic reach and a large network of care centers.
- Diversified service offerings catering to a broad patient demographic (pediatric to adult).
- Strong brand recognition and established relationships with referral sources.
- Experience in integrating acquired entities and operations.
Weaknesses
- High employee turnover and challenges in recruiting and retaining skilled caregivers.
- Dependence on government reimbursement rates (Medicare/Medicaid), which can be subject to change.
- Significant debt burden from past acquisitions and operational costs.
- Complexity in managing a large, decentralized operational structure.
Opportunities
- Increasing demand for home-based care due to an aging population and patient preference.
- Expansion into new geographic markets and service lines.
- Leveraging technology to improve care delivery efficiency and patient monitoring.
- Growth in post-acute care and chronic disease management services.
Threats
- Intensifying competition from national and regional home health providers.
- Changes in healthcare regulations and reimbursement policies.
- Rising labor costs and shortages of qualified healthcare professionals.
- Potential for data breaches and cybersecurity risks in healthcare.
Competitors and Market Share
Key Competitors
- LHC Group (LHCG)
- Amedisys Inc. (AMED)
- Option Care Health Inc. (OPCH)
- Home Instead Senior Care (Private)
Competitive Landscape
Aveanna's competitive advantages lie in its broad service offering and significant scale. However, it faces intense competition from specialized providers and larger, more established players. Challenges include maintaining consistent quality of care across a large network and managing labor costs, which are critical differentiators for competitors.
Major Acquisitions
Premier Home Healthcare
- Year: 2017
- Acquisition Price (USD millions):
- Strategic Rationale: Foundation of Aveanna Healthcare Holdings Inc., combining multiple home health providers to create a larger, more diversified entity.
Interim Healthcare
- Year: 2017
- Acquisition Price (USD millions):
- Strategic Rationale: Further expanded the company's reach and service offerings in the home healthcare market.
Growth Trajectory and Initiatives
Historical Growth: Aveanna has experienced rapid growth, primarily through strategic acquisitions that have expanded its service lines and geographic footprint. Organic growth has been present but often overshadowed by the inorganic growth strategy. The company has aimed to consolidate fragmented markets and achieve economies of scale.
Future Projections: Future growth is expected to be driven by continued demand for home healthcare services, potential for further strategic acquisitions, and expansion of its service offerings. Analysts' projections often focus on revenue growth, with profitability dependent on the company's ability to manage costs and optimize operational efficiencies.
Recent Initiatives: Recent initiatives have likely focused on operational efficiency improvements, integration of acquired businesses, enhancing caregiver recruitment and retention strategies, and potentially exploring new service lines or technological advancements to improve care delivery.
Summary
Aveanna Healthcare Holdings Inc. is a significant player in the fragmented home healthcare market, with a broad range of services and a substantial geographic footprint. Its growth has been primarily acquisition-driven, leading to considerable scale. However, the company faces challenges in profitability due to high operating costs, particularly labor, and a significant debt burden. Continued demand for home care is a positive driver, but navigating regulatory changes and competitor pressures will be crucial for its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC filings (10-K, 10-Q)
- Financial news and data providers (e.g., Bloomberg, Refinitiv)
- Industry analysis reports
Disclaimers:
This JSON output is generated for informational purposes only and does not constitute financial advice. Data accuracy and completeness are subject to the availability and reliability of the source information. Market share data is an estimation based on available information and may not reflect precise current figures. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aveanna Healthcare Holdings Inc
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com | ||
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.